Women’s Board

Established in 1947, the Women’s Board has allocated over $19 million in funding to launch some of the Comprehensive Cancer Center’s most inventive and successful cancer research programs. The board funds innovative experimentation, enabling UChicago scientists to pursue promising avenues of investigation that would otherwise remain unexplored.

Its hallmark event, an annual gala, began in 1966 and quickly became one of the Chicago philanthropic scene’s must-attend events. Today, the Breakthrough Ball draws more than 500 civic and philanthropic leaders who share a commitment to advancing cancer prevention, care, and treatment, and enriching human life.

Executive Committee

Diane H. Reilly
President

Laura Werner
Special Advisor

Tricia Cox
First Vice President

Cindy Chereskin
Second Vice President

Kristi Nuelle
Treasurer

Nancy Gupta
Program Chair

Linda Burns Coleman
Future Planning Chair

Kristi Nuelle
Nominating Chair

Karen Riley McEniry
Marketing & Communications

Jean Atchison
Board of Trustees Liaison

Mary Conrad
Sustaining Member Liaison

Meredith Parrish
Barbara Sessions
Annual Appeal Chairs

Beth Eugenio
Elizabeth Luttig
Benefit Chairs

Annemette B. Clausen
External Events Chair

Members at Large of the Executive Committee

Pim Alley
Jennifer Kasten
Eileen Murphy
Jennifer Rhind
Karen Slimmon

Members

Liz Adams
Karen Anagnost
Margaret Benjamin
Marta Bonner
Terri Brady
Terry Brumfield
Annette Carroll
Wendy Chronister Rogers
Ruth Colby
Anne Cox
Nancy Crane
Joan Crouch
Rebecca Cumbee
Diana Da Miano
Rebecca (Becky) Davidson
Lidia Devonshire
Patsy Dickerson
Marie Dzanis
Linda Finkel
Alexandra Fox
Lena Helms
Whitley Bouma Herbert
Anne Hokin
Blaine Kinney Johnson
Robin Josephs
Kathy Kompare
Jody Krug-Schulte
Astrid McKinnon
Leslie McLean
Carla Miller
Elissa Morgante
Yoko Mosher
Hilary Oran
Jody Oshita-Bajor
Bliss Packer
Karen Pearson
Katie Peck
Jill Pollock
Laura Neiman Rifkin
Anne Rockey
Liz Ryan
Wells Ryan
Joanne Schell
April Schink
Mary Skoning
Cia Souleles
Diane Thomas
Nancy Voss
Tina Wardrop
Laura Werner
Alice Williams-Verhoeven

Sustaining Members

Allison Bacon
Laurie Bay
Geraldine Balut Coleman
Missy Derse
Julie Diermeier
Laura Gillette
Carol Horschke
Linda Kimball
Elaine Levinson
Ruth Ann McGuinnis
Kathryn Miller
Suzanne Pierce
Sandy Reese
Jennifer Kamp Tretheway

Honorary Members

Patricia Auch
Wendy Becker-Payton
Beverly Bell
Sharon Brix McMahan
Merle Goldblatt Cohen
Mary Ellen Connellan
Cynthia Reusché
Kathy Walgreen

Grand Total of approximately $19,722,070


  • 2018

    $150,000 Team Science
    $150,000 Janet D. Rowley Discovery Fund
    $150,000 Ben May Department for Cancer Research
    $100,000 Spotlight: Survivorship in AYA Patients
    $100,000 Spotlight: Cancer Risk Reduction
    $100,000 Innovation in Breast Cancer Screening & Diagnosis
    $100,000 Human Tissue Resource Center
    $80,000 The Committee on Cancer Biology
    $70,000 Personalized Cancer Treatments
    $50,000 Women’s Board Senior Scholar
    $50,000 Radiotracers for Cancer Detection & Monitoring Treatment
    $50,000 Near the Payline Grant Applications

    2018 Total: $1,150,000


  • 2017

    $350,000 The Microbiome and Cancer
    $350,000 The Cancer Epitranscriptome Ben May Department for Cancer Research
    $150,000 Team Science
    $150,000 Ben May Department for Cancer Research
    $150,000 Janet D. Rowley Discovery Fund
    $100,000 Spotlight: Prostate Cancer
    $100,000 Spotlight: Women’s Cancer
    $100,000 Spotlight: Pediatric Cancer
    $100,000 Human Tissue Resource Center
    $80,000 Committee on Cancer Biology
    $70,000 Personalized Cancer Treatments

    2017 Total: $1,700,000


  • 2016

    $150,000 Team Science
    $150,000 Ben May Department for Cancer Research
    $150,000 Janet D. Rowley Discovery Fund
    $100,000 Human Tissue Resource Center
    $100,000 Oral Microbiome and Cancer Risk
    $80,000 Committee on Cancer Biology
    $70,000 Personalized Cancer Treatments
    $50,000 Genetics of Chemotherapy-induced Side Effects Project
    $50,000 Novel Cyclotron-Based Radiotracers for Cancer Research

    2016 Total: 900,000


  • 2015

    $280,000 Team Science
    $150,000 Ben May Department for Cancer Research
    $145,000 Janet D. Rowley Discovery Fund
    $100,000 Human Tissue Resource Center
    $90,000 Precision Oncology- Immunotherapy
    $80,000 Committee on Cancer Biology
    $70,000 Chicago Multiethnic Prevention & Surveillance Study (COMPASS)
    $50,000 Personalized Cancer Care Consortium
    $35,000 Innovative Early Phase Clinical Research by UCCCC Investigators


  • 2014

    $280,000 Team Science
    $150,000 Ben May Department for Cancer Research
    $100,000 Human Tissue Resource Center Chicago
    $85,000 Multiethnic Cohort
    $80,000 Committee on Cancer Biology
    $50,000 Personalized Cancer Care Consortium
    $30,000 Translational and Personalized Precision Oncology
    $25,000 Human Imaging Research Office (HIRO)
    $25,000 Continuing Umbrella of Research Experience (CURE)


  • 2013

    $150,000 Ben May Department for Cancer Research
    $150,000 Team Science
    $100,000 Human Tissue Resource Center
    $80,000 Committee on Cancer Biology
    $50,000 Chicago Multiethnic Cohort
    $50,000 Personalized Cancer Care Consortium
    $35,000 Translational and Personalized Precision Oncology
    $10,000 Program in Cancer Economics


  • 2012

    $200,000 to the Ben May Department of Cancer Research
    $100,000 to the Human Tissue Resource Center
    $80,000 to Committee on Cancer Biology
    $50,000 to the Cancer Economics Program
    $50,000 to the Magnetic Resonance Imaging Research Center (MRIRC)
    $50,000 to the Chicago Multiethnic Cohort
    $50,000 to the Personalized Cancer Care Consortium
    $20,000 to Informatics for Neuroblastoma Research


  • 2011

    $100,000 to the Human Tissue Resource Center
    $80,000 to Committee on Cancer Biology
    $75,000 to the Cancer Economics Program
    $75,000 to BMDCR
    $70,000 to Bioinformatics/Biostatistics in Basic Science
    $50,000 to Clinical Trials Operational Efficiency via Computer-aided Knowledge (CLOCK)
    $40,000 to Prostate Cancer SPORE: Gene Expression Analysis
    $40,000 to the Committee on Clinical Pharmacology and Pharmacogenomics
    $10,000 to Pediatric Cancer: New Therapies for Neuroblastoma


  • 2006-2011

    $1,500,000 Women’s Board Drug Discovery Lab (capital campaign)


  • 2010

    $200,000 to BMDCR
    $120,000 to Committee on Cancer Biology
    $75,000 to Basic Science Informatics
    $60,000 to the Human Tissue Resource Center
    $40,000 to Committee on Clinical Pharmacology
    $25,000 to Information Technology to Accelerate Translational Research
    $15,000 to Chemical library and pilot screen for soft tissue sarcoma
    $50,000 to Study of malignant cancer stem cells to identify new therapies for prostate cancer
    $25,000 to Immunology research in acute myeloid leukemia


  • 2009

    $200,000 to BMDCR
    $120,000 to Committee on Cancer Biology
    $60,000 to the Human Tissue Resource Center
    $50,000 to basic Science Informatics
    $10,000 to Drug Discovery and Advanced Instrumentation
    $150,000 to Interdisciplinary Cancer Research


  • 2008

    $200,000 to BMDCR
    $120,000 to the Committee on Cancer Biology
    $120,000 to Bio- and Clinical Informatics
    $60,000 to the Human Tissue Resource Center
    $40,000 to Epidemiology and Research Recruitment Core (ERRC)
    $40,000 to the Pediatric Survivorship Clinic
    $20,000 to Drug Discovery and Advanced Instrumentation


  • 2007

    $200,000 to BMDCR
    $133,000 to Bio-clinical informatics
    $117,000 to the Committee on Cancer Biology
    $90,000 to Drug Discovery, Drug Development, and Advanced Instrumentation
    $60,000 to Human Tissue Resource Core


  • 2006

    $200,000 to BMICR
    $150,000 to Drug Discovery, Drug Development, and Advanced Instrumentation
    $110,000 to the Committee on Cancer Biology
    $60,000 to Biomedical informatics
    $50,000 to Clinical Informatics
    $30,000 to Human Tissue Procurement Facility


  • 2005

    $150,000 to BMICR
    $108,000 to the Committee on Cancer Biology
    $30,000 to Human Tissue Procurement Facility
    $70,000 to cGMP Facility
    $120,000 to Drug Discovery, Drug Development, and Advanced Instrumentation
    $75,000 to Bioinformatics
    $79,000 to Clinical Informatics
    $3,000 to Small Animal Imaging


  • 2004

    $272,000 to the Genetics-Proteomics-Drug Discovery Continuum
    $150,000 to the Ben May Institute for Cancer Research
    $100,000 to the Committee on Cancer Biology
    $63,000 to the cGMP Facility
    $40,000 to UCCRC AdvanceLink


  • 2003

    $225,000 to the Genetics-Proteomics-Drug Discovery Continuum
    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to the Committee on Cancer Biology
    $30,000 to UCCRC AdvanceLink
    $30,000 to Population Science and Genetics
    $18,500 to Functional Genomics
    $14,000 to Magnetic Resonance Imaging Spectroscopy
    $7,000 to Laser Capture Microdissection


  • 2002

    $200,000 to the Genetics-Proteomics-Drug Discovery Continuum
    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to the Committee on Cancer Biology
    $45,000 to Breast Cancer Research
    $40,000 to Human Cellular Transplant and Gene Therapy Facility
    $40,000 to Population Science and Genetics
    $5,000 to the Tumor Immunology Program


  • 2001

    $200,000 to the Genetics-Proteomics-Drug Discovery Continuum
    $120,000 to the Ben May Institute for Cancer Research
    $95,000 to the Committee on Cancer Biology
    $73,600 to Cancer Resource Center and Breast Cancer research
    $52,100 for Genetic Microchips


  • 2000

    $200,000 to Peer Reviewed Research funds relating specifically to Gene Array Technology
    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to Committee on Cancer Biology
    $60,000 to Laser Capture Microdissection
    $20,000 to Development of Human Cellular Transplant & Gene Therapy Facility


  • 1999

    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to Committee on Cancer Biology
    $80,000 to Immunology research in Critical Pathways of Cell Growth
    $50,000 to Cancer Prevention and Control
    $25,000 to Embryonic Stem Cell Facility
    $25,000 to Phosphor Imager


  • 1998

    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to Committee on Cancer Biology
    $80,000 to Digital Light Microscopy
    $50,000 to Cancer Prevention and Control
    $50,000 to Embryonic Stem Cell Facility


  • 1997

    $120,000 to the Ben May Institute for Cancer Research
    $100,000 to Committee on Cancer Biology
    $50,000 to Embryonic Stem Cell Facility
    $30,000 to Biomedical Research Awards


  • 1996

    $120,000 to the Ben May Institute for Cancer Research
    $50,000 to Committee on Cancer Biology
    $35,000 to Monoclonal Antibody Facility


  • 1995

    $100,000 to the Ben May Institute for Cancer Research
    $55,000 to Monoclonal Antibody Facility
    $25,000 for Fellowship to Scott Holley


  • 1994

    $120,000 to the Ben May Institute for Cancer Research
    $35,000 to Monoclonal Antibody Facility


  • 1993

    $168,870 to the Ben May Institute for Cancer Research


  • 1992

    $173,000 to the Ben May Institute for Cancer Research
    $5,000 to Dr. Monica Morrow


  • 1947-1991

    Approximately $2.5 million in funds to the Ben May Institute for Cancer Research


EVENTS

Women's Board's Breakthrough Ball

November 9, 2019

This hallmark event began in 1966 and quickly became one of the Chicago philanthropic scene’s must-attend events. Today, it draws more than 500 civic and philanthropic leaders who share a commitment to advancing cancer prevention, care, and treatment.

Buy Tickets >

Women's Board's May Dinner

Spring 2020

The Women’s Board’s May Dinner is an invitation only event for board members. If you are interested in learning more about the board’s fundraising efforts and how you can get involved, please click the link below to contact us.

Learn More >

ANNUAL APPEAL

Cancer Can't Wait

For over 70 years, the University of Chicago Cancer Research Foundation Women’s Board has been providing seed funding to support the world’s most leading-edge research.

We could never have made the progress that we’ve made without your help.

Make your gift today >

Follow the Women's Board
   
Top